Sanofi Patient Connection is a comprehensive program designed to assist patients through three main types of support:

  1. Reimbursement Connection
  2. Patient Assistance Connection
  3. Resource Connection

Therapies Offered

  • Adacel® (tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine absorbed)

  • Adlyxin™ (lixisenatide) injection

  • ADMELOG® (insulin lispro injection) 100 Units/mL

  • Apidra® (insulin glulisine [rDNA origin] injection

  • Clolar® (clofarabine) Injection

  • Elitek® (rasburicase)

  • Imovax® Rabies Vaccine [Human Diploid Cell]

  • Jevtana® (cabazitaxel) Injection

  • Lantus® (insulin glargine [rDNA origin] injection)

  • Lovenox® (enoxaparin sodium injection)

  • Menactra® Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine

  • Mozobil® (plerixafor injection)

  • Multaq® (dronedarone) Tablets

  • Priftin® (rifapentine) Tablets

  • SOLIQUA™ 100/33 (insulin glargine & lixisenatide injection) 100 Units/mL and 33 mcg/mL

  • SYNVISC ONE® HYLAN G-F 20

  • SYNVISC® HYLAN G-F 20

  • Tenivac® (tetanus and diphtheria toxoids adsorbed)

  • Thymoglobulin® [Anti-thymocyte Globulin (Rabbit)]

  • Toujeo® (insulin glargine [rDNA origin] injection, 300 units/mL)

  • Zaltrap® (ziv-aflibercept)